Answers are grounded in this paper and cite their sources.
Shows antibody S22019F enables analysis of KIR2DS1+ NK and T cells, suggesting enhanced research applications.
T cells. Collectively, these findings underscore the value of S22019F as a reagent that selectively recognises KIR2DS1, enabling improved analyses of KIR2DS1-bearing lymphocytes in fundamental and clinical research.
No takes yet. Share an insight, caveat, or question.
Bilev et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: